Tissue Factor Pathway Inhibitor Modulates Fibrin Deposition In The Brain In a Manner That Is Independent Of Thrombomodulin and Activated Protein C

被引:0
|
作者
Maroney, Susan A.
Ellery, Paul E. R.
Martinez, Nicholas D.
Zogg, Mark
Gilbert, Gary E.
Weiler, Hartmut
Mast, Alan E.
机构
关键词
D O I
10.1182/blood.V122.21.2302.2302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2302
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition
    Maroney, S. A.
    Cooley, B. C.
    Sood, R.
    Weiler, H.
    Mast, A. E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (01) : 111 - 117
  • [2] Combined tissue factor pathway inhibitor (TFPI) and Thrombomodulin (TM) deficiency produces an augmented hypercoagulable state with tissue specific fibrin deposition
    Maroney, Susan A.
    Cooley, Brian C.
    Sood, Rashmi
    Weiler, Hartmut
    Mast, Alan E.
    BLOOD, 2007, 110 (11) : 85A - 85A
  • [3] Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C
    Gardiner, C.
    Cohen, H.
    Austin, S. K.
    Machin, S. J.
    Mackie, I. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (12) : 2724 - 2726
  • [4] Pregnancy morbidity, tissue factor pathway inhibitor deficiency and resistance to activated protein C
    Gardiner, C.
    Cohen, H.
    Machin, S. J.
    Mackie, I. J.
    THROMBOSIS RESEARCH, 2007, 119 : S104 - S105
  • [5] Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation
    Li, Xian
    Song, Xiaohong
    Mahmood, Dlovan F. D.
    Sim, Martha M. S.
    Bidarian, Sara J.
    Wood, Jeremy P.
    THROMBOSIS RESEARCH, 2023, 230 : 84 - 93
  • [6] Protein S Released From Stimulated Platelets Has Anticoagulant Activity Independent of Activated Protein C and Tissue Factor Pathway Inhibitor (TFPI)
    Heeb, Mary J.
    Duan, Erning
    BLOOD, 2010, 116 (21) : 492 - 493
  • [7] Inhibition of protease generation by activated protein C in the absence and presence of tissue factor pathway inhibitor
    Kaiser, B
    Callas, D
    Hoppensteadt, D
    Fareed, J
    BLOOD, 1995, 86 (10) : 3490 - 3490
  • [8] Inhibition of tissue factor pathway inhibitor (TFPI) exacerbates fibrin deposition in crescentic glomerulonephritis (GN).
    Erlich, JH
    Holdsworth, SR
    Tipping, PG
    KIDNEY INTERNATIONAL, 1997, 51 (04) : 1313 - 1313
  • [9] INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR (TFPI) EXACCERBATES FIBRIN DEPOSITION IN CRESCENTIC GLOMERULONEPHRITIS (GN)
    TIPPING, P
    ERLICH, J
    HOLDSWORTH, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 856 - 856
  • [10] Expression of tissue factor and tissue factor pathway inhibitor in arthritic synovial tissues: Correlation with synovial fibrin deposition and inflammation.
    Busso, N
    Morard, C
    Salvi, R
    Chobaz-Peclat, V
    So, A
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S161 - S161